|
HS Code |
825436 |
| Product Name | Fmoc-D-3-Cyanophenylalanine |
| Synonym | Fmoc-D-m-CN-Phe-OH |
| Cas Number | 205495-00-5 |
| Molecular Formula | C24H18N2O4 |
| Molecular Weight | 398.41 |
| Purity | ≥98% |
| Appearance | White to off-white powder |
| Solubility | DMSO, DMF, MeOH |
| Storage Temperature | 2-8°C |
| Protecting Group | Fmoc (9-fluorenylmethoxycarbonyl) |
| Chirality | D-isomer |
| Functional Groups | Amino acid, cyano, Fmoc |
As an accredited Fmoc-D-3-Cyanophenylalanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical Fmoc-D-3-Cyanophenylalanine is packaged in a sealed amber glass vial containing 1 gram, labeled with product details. |
| Shipping | Fmoc-D-3-Cyanophenylalanine is shipped in secure, sealed packaging to protect it from moisture and contamination. During transit, the chemical is maintained at room temperature and handled in compliance with regulations for safe transport of laboratory reagents. Accompanying documentation ensures traceability and proper handling upon delivery. |
| Storage | **Fmoc-D-3-Cyanophenylalanine** should be stored in a tightly sealed container, protected from light and moisture. Keep at 2-8°C (refrigerator temperature) in a dry, well-ventilated place. Avoid exposure to strong acids, bases, and oxidizing agents. Ensure the storage area is suitable for chemicals and clearly labeled, following standard safety and handling instructions for amino acid derivatives. |
Applications of Fmoc-D-3-Cyanophenylalanine in Industrial ManufacturingAs a direct manufacturer of Fmoc-D-3-Cyanophenylalanine, we supply this protected non-standard amino acid to specialized sectors that demand reliable quality and precise performance, supporting key innovations in peptide research, pharmaceutical development, diagnostic technology, and advanced material science. 1. Solid-Phase Peptide Synthesis (SPPS) for Pharmaceutical ResearchPeptide manufacturers use Fmoc-D-3-Cyanophenylalanine as a building block to introduce cyano-functionalized D-phenylalanine residues into synthetic peptides, enabling medicinal chemists to explore novel structures that can enhance receptor selectivity or improve metabolic stability. The unique electronic profile of the cyano group expands structure-activity relationship (SAR) studies in early-stage drug discovery pipelines. After resin loading, this amino acid incorporates into the peptide chain at specified cycles during automated or batch-wise SPPS using conventional Fmoc-chemistry protocols, followed by resin cleavage and purification steps. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Custom Peptide Manufacturing for Diagnostic Kit ReagentsLeading producers of immunoassay and molecular diagnostic kits incorporate Fmoc-D-3-Cyanophenylalanine into synthetic peptide antigens to improve epitope recognition or label sites for conjugation. Its unique side chain can enable site-specific modifications and enhanced performance in diagnostic binding assays. Production typically employs fully automated parallel peptide synthesis, integrating this amino acid into medium-length, highly purified peptides for use in ELISA calibrators or lateral flow test components. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Preparation of Cyano-Functionalized Peptide Conjugates for Targeted Drug DeliverySpecialty peptide manufacturers employ Fmoc-D-3-Cyanophenylalanine as a key precursor for the synthesis of peptide-drug conjugates and targeting ligands, utilizing its reactive cyano group for bio-orthogonal ligation or as an attachment site for payloads. This enables downstream chemical conjugation to cytotoxic agents or fluorescent dyes, yielding site-specifically modified constructs essential for modern targeted therapy platforms and imaging applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Synthesis of Modified Peptide Standards for Analytical and Quality ControlAnalytical laboratories and pharmaceutical QC units utilize Fmoc-D-3-Cyanophenylalanine to generate reference peptide standards containing precise modifications required for mass spectrometry calibration, impurity profiling, and process validation. Its defined structure allows accurate benchmarking in LC-MS, HPLC, and peptide mapping protocols, particularly where traceability to modified residues is essential. The material becomes part of customized synthetic workflows for primary and secondary peptide standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Fmoc-D-3-Cyanophenylalanine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the world of peptide synthesis, Fmoc-D-3-Cyanophenylalanine stands out not only because of its chemical structure—Fmoc-protected, D-configuration, and a para-cyano group—but because this amino acid unlocks specific directions for researchers and developers. Having produced specialty amino acids for decades, I have watched the demand for advanced building blocks surge as peptide therapeutics, diagnostics, and engineered proteins became more ambitious. Fmoc-D-3-Cyanophenylalanine, model Fmoc-D-m-CN-Phe and routinely produced at greater than 99% purity by HPLC, fits precisely into these demanding applications.
Our clients in pharmaceutical and biotech labs look to us for amino acids that perform precisely and consistently in peptide synthesis. D-configuration amino acids play a central role in modulating bioactivity, metabolic stability, and conformational preference. The specific placement of a cyano group at the meta position on the aromatic ring in this molecule pushes the chemical landscape even further. Researchers have adopted Fmoc-D-3-Cyanophenylalanine to introduce bioorthogonal handles and differentiate between stereoisomers during solid-phase peptide synthesis. By making D-forms available at preparative scales, we see our customers push the edge of synthetic biology and protein engineering, expanding the catalog of available proteins not found in nature.
As a manufacturer—not a trader or middleman—we invest most of our attention in the reproducibility of each batch. Fmoc-D-3-Cyanophenylalanine presents a set of synthesis challenges, particularly when aiming for minimal racemization. The asymmetric synthesis route we choose minimizes racemization risk, as we bring in D-precursors and carefully control each reaction step. Every batch is characterized using NMR, mass spectrometry, and we rely on both chiral HPLC and traditional HPLC monitoring. Over the years, we’ve identified certain solvents and coupling agents that enhance yield and purity, and we strictly avoid conditions that could hydrolyze the Fmoc group or cause potential epimerization at the alpha carbon.
Users routinely ask about the protective schemes on amino acids. The Fmoc group, well established in SPPS (solid-phase peptide synthesis), offers straightforward removal with 20% piperidine in DMF. Its removal does not disrupt sensitive side chains. Direct feedback from peptide chemists has told us that Fmoc-D-3-Cyanophenylalanine unblocks easily, yielding clean removal without by-product issues. Compared to Boc-protected analogs, Fmoc versions operate under milder deprotection regimes, which reduces side-chain damage and preserves the cyano functionality, an essential consideration in synthetic strategies where integrity of each substituent counts.
The meta-cyano group on this phenylalanine derivative offers a dual function—enhancing electronic effects for downstream conjugation or labeling and adding a site for bioconjugation. In small molecule drug research, the cyano group has drawn attention for its role as a versatile handle that can participate in click chemistry, palladium-catalyzed coupling, or form the basis for fluorescent tag introduction. In our hands, its introduction is tightly controlled to prevent over-reaction with nucleophiles or hydrolysis. The cyano group also shifts the aromatic electron density, influencing peptide folding in unpredictable—but often useful—ways. Our academic collaborators find this especially valuable when tuning peptide-protein interactions or probing receptor selectivity.
Peptide stability is a challenge throughout the drug development pipeline. By introducing D-forms such as D-3-Cyanophenylalanine, researchers have created peptide sequences that resist proteolytic enzymes and show greater stability in biological fluids. We’ve observed customers working in both animal models and cell-free systems. Their feedback is unanimous: including a D-amino acid at key sites in a peptide sequence can slow degradation dramatically. Unlike L-counterparts, D-forms often commute through biological matrices with less recognition and faster clearance—critical for imaging probes or short-acting peptide drugs.
Many commercial sources repackage or outsource their production. We control the entire synthetic route for our Fmoc-D-3-Cyanophenylalanine, from raw starting materials to purification. This vertical integration gives us consistent batch quality and greater flexibility when a client requests higher purities or specific salt forms. Larger research houses ask us for custom scales and modifications—we respond by adjusting batch sizes, isolation methods, and final formulation as needed, always ready to address the nucleophilicity of the cyanophenylalanine’s side chain or provide more detailed impurity profiling.
Our relationships with developers never pause at the point of purchase. Peptide chemists who try to build longer, more complex chains using Fmoc-D-3-Cyanophenylalanine have surfaced a few recurring issues: resin swelling, low coupling efficiency under certain microwave protocols, and occasional by-product formation when scaling up. We respond in several ways—by optimizing the solvent system, using high-activity coupling reagents like HATU, pre-activating the amino acid when necessary, and providing detailed troubleshooting tips. For one researcher, we advised reducing the coupling time, which eliminated most of the undesired side reactions. These solutions emerge from a cycle of using, observing, and adjusting our own production parameters whenever users surface a new technical challenge.
Clients often approach us with analytical requests that go far beyond a simple certificate of analysis. Structural confirmation must match their project requirements, with stress on verifying the D-chirality and intactness of the cyano group. We maintain extensive spectral archives and analytical overlays for each batch, and labs frequently request cross-reference material for their own NMR or LC-MS. We make these available to foster confidence in downstream work. If a customer spots an inconsistency or faces a transfer difficulty, access to raw data often resolves questions rapidly—sometimes revealing a need to tweak the protocol, sometimes pointing to a handling issue in the client’s lab.
Fmoc-D-3-Cyanophenylalanine holds up well under recommended conditions—dry, room temperature, inert atmosphere. We’ve noticed, though, that improper resealing after use can lead to hydrolysis of the Fmoc group or slow hydration of the cyano function, which may complicate later coupling. Comparing cryogenic and ambient storage across several years, we see minor degradation peaks by HPLC only when the compound is repeatedly exposed to air or moisture. To address this, we encourage users to return the material to a desiccator after every use and to aliquot material for large projects.
Producing Fmoc-D-3-Cyanophenylalanine at lab scale differs from delivering kilogram amounts. Early stage projects often only require a few hundred milligrams—but as projects move to animal models or clinical validation, demand quickly rises. The synthesis route we use does not simply scale by increasing reagent concentrations; temperature control, stirring efficiency, and purification throughput must be recalibrated at each stage. We’ve encountered bottlenecks in precipitation and filtration that triggered process adjustments: switching filter types, extending drying cycles under vacuum, and modifying chromatography protocols. Only experience honed by repeated upscaling lets us avoid loss or contamination at these critical steps.
Demand for modified amino acids continues to grow as new peptide drugs enter trials and researchers pursue noncanonical building blocks for innovative scaffolds. Fmoc-D-3-Cyanophenylalanine is at the center of this expansion, particularly for groups exploring site-specific conjugations, molecular imaging, or robust biostability. The drive towards more exacting purity levels, tighter impurity specifications, and expanded regulatory disclosure intensifies with each passing year. We respond to regulatory shifts by maintaining full traceability of source chemicals, process documentation, and residual solvent analysis for every lot. Government and private research funds both see value in this molecule, with project requests often focused on enhanced labeling or improved metabolic profiles.
Direct contact with our manufacturing team yields benefits that are hard to match through distributors or third parties. Customization ranks among the first motivators—our experience streamlines the introduction of isotopic labels, custom counterions, or impurity controls. In partnership with several large pharma companies, we developed process tweaks that reduce potential trace contaminants below published guidance for pharmaceutical intermediates, and users return with confidence when their preclinical batches run smoothly. Our regular participation in third-party proficiency tests for both purity and stereochemical assignment strengthens our production confidence and, by extension, the trust researchers place in us.
Maintaining a high-quality standard for Fmoc-D-3-Cyanophenylalanine means not just monitoring final product quality, but also considering the environmental footprint of each production cycle. Our operations follow stringent waste management, solvent recovery, and recycling procedures. We regularly invest in closed-system equipment to reduce exposure risk and pollution, and our staff undergoes ongoing safety training focused on handling challenging intermediates, including cyanide-containing precursors. We share our environmental audits with customers on request, reflecting our openness about safety and stewardship.
Some projects require more than standard amino acids. We work with innovators at universities, CROs, and pharmaceutical companies to adapt Fmoc-D-3-Cyanophenylalanine to a range of applications, including hydrogels, bioconjugates, or diagnostic kits. For instance, one client recently needed a multi-gram batch formulated with specific particle size restrictions for automated peptide synthesizers—a challenge we addressed by retooling our crystallization and milling steps. In another collaboration, we produced a series of Fmoc-D-3-Cyanophenylalanine analogs with altered alkyl groups, supporting a funded project exploring backbone rigidity in artificial receptor peptides.
Academic labs increasingly turn to us for reliable supplies of specialty amino acids, recognizing that the repeatability of peptide synthesis exercises hinges on dependable material. We support academic research by providing smaller aliquots, method notes, and troubleshooting guides tailored to educational needs. Students new to peptide chemistry benefit from having their results align closely with expectations—differences here can set a tone of confidence or frustration. Our own staff contributes by giving lectures on solid-phase peptide synthesis and best practices in handling protected amino acids. This effort ultimately fosters a wider community of well-trained scientists, many of whom return to us when they move into industry or advanced research settings.
Looking ahead, the uses for Fmoc-D-3-Cyanophenylalanine are only expanding. Ongoing research into antibody-drug conjugates, labeled peptide diagnostics, and industrial enzyme modification will demand even stricter stereochemical control, trace impurity measurement, and scale-up expertise. We maintain a forward-looking R&D program, testing new protective groups, coupling methods, and greener production alternatives. Our commitment extends beyond just supply—we seek active discussion with research partners to discover uncharted applications and design new derivatives according to real project needs.
Our experience as a direct producer of Fmoc-D-3-Cyanophenylalanine makes a difference at the laboratory and industrial scale. Regular feedback cycles with users, continual process optimization, and investment in analytical infrastructure keep our product ahead of generic competitors. The cyano group’s placement, D-form chirality, and tight Fmoc protection unlock research directions that classic L-phenylalanine derivatives or analogs can’t reach. In survey after survey, users identify low impurity profiles, consistent performance in SPPS protocols, and open, expert communication as reasons for loyalty to our material. These qualities stem not from slogans but from long practice in the realities of chemical manufacturing.
Quality chemical manufacturing goes beyond technical know-how. It grows out of an ongoing dialogue with scientists, a commitment to documentation and traceability, and a willingness to revisit every aspect of the production process in light of feedback and new demands. We invite research partners and commercial buyers alike to engage directly, drawing on decades of hard-won experience in amino acid chemistry. Our doors remain open to requests for custom synthesis, bulk supply, and collaborative troubleshooting.
As trends in synthetic biology, pharmaceuticals, and diagnostics increasingly depend on specialty amino acids, we see continued demand for precisely produced, thoroughly documented Fmoc-D-3-Cyanophenylalanine. The trust our users place in us derives not from marketing claims but from demonstrated reliability, transparent partnerships, and ability to support groundbreaking research. Our commitment to quality, safety, and sustainability reflects the industry’s highest standards and our own daily practice on the manufacturing floor.